LYFIBRYX
DEAD

Serial Number

86306995

Owner

H. Lundbeck A/S

Attorney

Claudia A. Smith

Filing Date

Jun 11, 2014

Add to watchlist:

No watchlists yet
View on USPTO

LYFIBRYX Trademark

Serial Number: 86306995 • Registration: 4681303

LYFIBRYX is a trademark filed by H. Lundbeck A/S on June 11, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

June 11, 2014

Registration Date

February 3, 2015

Published for Opposition

November 18, 2014

Cancellation Date

September 10, 2021

Goods & Services

Pharmaceutical preparations for the treatment and prevention of brain and nerve diseases and disorders, sanitary preparations for medical purposes; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, stroke, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents

Surgical apparatus and instruments for medical use; suture materials; medical diagnostic apparatus and instruments, namely, test kits for brain and nerve diseases and disorders; integrated medical examination systems comprised of medical instruments, computer hardware, and software for information management for use in web-based physical, psychological, and neurological examination and assessment of patients in person and at a remote, clinical setting; drug delivery systems, namely, medical instruments for providing information, guidance, and control of medicines

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 10, 2021 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 3, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 3, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2014 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 16, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 6, 2014 CRFA
ASSIGNED TO LIE
Sep 29, 2014 ALIE
ASSIGNED TO LIE
Sep 29, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 26, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2014 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2014 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2014 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2014 NWOS
NEW APPLICATION ENTERED
Jun 14, 2014 NWAP